Forskolin enhances in vivo bone formation by human mesenchymal stromal cells.


Activation of the protein kinase A (PKA) pathway with dibutyryl cyclic adenosine monophosphate (db-cAMP) was recently shown to enhance osteogenic differentiation of human mesenchymal stromal cells (hMSCs) in vitro and bone formation in vivo. The major drawback of this compound is its inhibitory effect on proliferation of hMSCs. Therefore, we investigated… (More)
DOI: 10.1089/ten.TEA.2011.0312


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics